NASDAQ:AMRS - Amyris Stock Price, Price Target & More

$6.34 +0.04 (+0.63 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$6.34
Today's Range$6.16 - $6.45
52-Week Range$1.86 - $9.30
Volume474,037 shs
Average Volume528,686 shs
Market Capitalization$313.08 million
P/E Ratio-2.08
Dividend YieldN/A
Beta0.13

About Amyris (NASDAQ:AMRS)

Amyris logoAmyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable ingredients. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and lubricants for industrial markets; Biofene ingredients for nutraceuticals and vitamins market; and renewable fuels for transportation fuels markets. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Receive AMRS News and Ratings via Email

Sign-up to receive the latest news and ratings for AMRS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Industrial organic chemicals
Sub-IndustryOil & Gas Refining & Marketing
SectorBasic Materials
SymbolNASDAQ:AMRS
CUSIP03236M10
Phone510-450-0761

Debt

Debt-to-Equity Ratio-0.78%
Current Ratio0.92%
Quick Ratio0.82%

Price-To-Earnings

Trailing P/E Ratio-2.08
Forward P/E Ratio-10.75
P/E GrowthN/A

Sales & Book Value

Annual Sales$143.45 million
Price / Sales2.20
Cash FlowN/A
Price / CashN/A
Book Value($10.05) per share
Price / Book-0.63

Profitability

EPS (Most Recent Fiscal Year)($3.05)
Net Income$-77,390,000.00
Net Margins-53.95%
Return on EquityN/A
Return on Assets-96.89%

Miscellaneous

Employees440
Outstanding Shares49,690,000

How to Become a New Pot Stock Millionaire

Amyris (NASDAQ:AMRS) Frequently Asked Questions

What is Amyris' stock symbol?

Amyris trades on the NASDAQ under the ticker symbol "AMRS."

When did Amyris' stock split? How did Amyris' stock split work?

Shares of Amyris reverse split on Tuesday, June 6th 2017. The 1-15 reverse split was announced on Tuesday, June 6th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2017. An investor that had 100 shares of Amyris stock prior to the reverse split would have 7 shares after the split.

How were Amyris' earnings last quarter?

Amyris Inc (NASDAQ:AMRS) issued its quarterly earnings data on Thursday, March, 15th. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by $0.24. The biotechnology company earned $80.59 million during the quarter, compared to analysts' expectations of $68.14 million. The company's quarterly revenue was up 262.4% compared to the same quarter last year. During the same period last year, the firm earned ($0.09) earnings per share. View Amyris' Earnings History.

When is Amyris' next earnings date?

Amyris is scheduled to release their next quarterly earnings announcement on Monday, May, 14th 2018. View Earnings Estimates for Amyris.

What price target have analysts set for AMRS?

3 brokerages have issued 1-year target prices for Amyris' shares. Their forecasts range from $4.00 to $15.00. On average, they anticipate Amyris' share price to reach $9.6667 in the next year. View Analyst Ratings for Amyris.

Who are some of Amyris' key competitors?

Who are Amyris' key executives?

Amyris' management team includes the folowing people:
  • Mr. John G. Melo, Pres, CEO & Director (Age 52)
  • Dr. Joel R. Cherry Ph.D., Pres of R&D (Age 57)
  • Mr. Raffi Mark Asadorian, Consultant (Age 49)
  • Ms. Kathleen Valiasek, Chief Financial Officer (Age 54)
  • Mr. Eduardo Alvarez, Chief Operating Officer

Has Amyris been receiving favorable news coverage?

Media stories about AMRS stock have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Amyris earned a media sentiment score of 0.13 on Accern's scale. They also gave press coverage about the biotechnology company an impact score of 46.88 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of Amyris?

Shares of AMRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Amyris' stock price today?

One share of AMRS stock can currently be purchased for approximately $6.34.

How big of a company is Amyris?

Amyris has a market capitalization of $313.08 million and generates $143.45 million in revenue each year. The biotechnology company earns $-77,390,000.00 in net income (profit) each year or ($3.05) on an earnings per share basis. Amyris employs 440 workers across the globe.

How can I contact Amyris?

Amyris' mailing address is 5885 HOLLIS STREET SUITE 100, EMERYVILLE CA, 94608. The biotechnology company can be reached via phone at 510-450-0761 or via email at [email protected]


MarketBeat Community Rating for Amyris (AMRS)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  156 (Vote Outperform)
Underperform Votes:  214 (Vote Underperform)
Total Votes:  370
MarketBeat's community ratings are surveys of what our community members think about Amyris and other stocks. Vote "Outperform" if you believe AMRS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMRS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Amyris (NASDAQ:AMRS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Amyris in the last 12 months. Their average twelve-month price target is $9.6667, suggesting that the stock has a possible upside of 52.47%. The high price target for AMRS is $15.00 and the low price target for AMRS is $4.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.502.67
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.6667$9.6667$9.50$26.3333
Price Target Upside: 52.47% upside43.42% upside94.67% upside652.38% upside

Amyris (NASDAQ:AMRS) Consensus Price Target History

Price Target History for Amyris (NASDAQ:AMRS)

Amyris (NASDAQ:AMRS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/2/2018HC WainwrightReiterated RatingBuy$15.00LowView Rating Details
3/20/2018B. RileySet Price TargetBuy -> Buy$8.00 -> $10.00LowView Rating Details
11/29/2017CowenReiterated RatingHold$4.00HighView Rating Details
1/11/2017Rodman & RenshawReiterated RatingBuy$60.00N/AView Rating Details
9/28/2016Singular ResearchReiterated RatingBuy$42.00N/AView Rating Details
(Data available from 4/21/2016 forward)

Earnings

Amyris (NASDAQ:AMRS) Earnings History and Estimates Chart

Earnings by Quarter for Amyris (NASDAQ:AMRS)

Amyris (NASDAQ:AMRS) Earnings Estimates

2018 EPS Consensus Estimate: ($0.53)
2019 EPS Consensus Estimate: $0.16
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.38)($0.38)($0.38)
Q2 20181($0.21)($0.21)($0.21)
Q3 20181($0.11)($0.11)($0.11)
Q4 20181$0.17$0.17$0.17
Q1 20191($0.12)($0.12)($0.12)
Q2 20191$0.00$0.00$0.00
Q3 20191$0.07$0.07$0.07
Q4 20191$0.21$0.21$0.21

Amyris (NASDAQ AMRS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/14/2018($0.20)N/AView Earnings Details
3/15/2018Q4 2017$0.07($0.17)$68.14 million$80.59 millionViewListenView Earnings Details
11/14/2017Q3 2017($0.77)($0.81)$36.30 million$24.20 millionViewN/AView Earnings Details
8/10/2017Q2 2017($1.06)($1.41)$23.68 million$25.68 millionViewN/AView Earnings Details
5/15/2017Q1 2017($1.35)($1.95)$32.30 million$13.00 millionViewN/AView Earnings Details
3/2/2017Q4 2016($0.75)($1.50)$38.72 million$32.20 millionViewListenView Earnings Details
11/2/2016Q316($0.90)($1.05)$33.61 million$26.50 millionViewN/AView Earnings Details
8/4/2016Q2($1.80)($0.90)$15.23 million$9.60 millionViewN/AView Earnings Details
5/10/2016Q1($1.95)($2.55)$10.39 million$8.80 millionViewListenView Earnings Details
3/9/2016Q4($1.50)($2.40)$32.44 million$9.80 millionViewListenView Earnings Details
11/5/2015Q315($2.55)($3.45)$8.84 million$8.60 millionViewN/AView Earnings Details
8/6/2015Q215($4.65)($7.95)$15.66 million$7.80 millionViewN/AView Earnings Details
5/5/2015Q115($1.50)($6.15)$21.40 million$7.90 millionViewN/AView Earnings Details
2/24/2015Q414($3.00)($12.60)$20.12 million$11.60 millionViewN/AView Earnings Details
11/4/2014Q314($2.10)($4.20)$20.51 million$16.34 millionViewN/AView Earnings Details
8/7/2014Q214($5.55)($5.25)$12.36 million$9.30 millionViewN/AView Earnings Details
5/8/2014Q114($4.80)($5.40)$13.50 million$17.90 millionViewN/AView Earnings Details
2/25/2014Q413($3.60)($3.90)$18.66 million$15.40 millionViewN/AView Earnings Details
10/31/2013Q313($4.50)($4.80)$13.59 million$7.00 millionViewN/AView Earnings Details
8/8/2013Q2 2013($4.80)($5.10)$11.47 million$10.80 millionViewN/AView Earnings Details
4/30/2013Q1 2013($5.85)($5.85)$9.80 million$7.87 millionViewN/AView Earnings Details
2/19/2013Q4 2012($7.65)($7.35)$10.68 million$5.90 millionViewN/AView Earnings Details
11/6/2012Q312($9.45)($3.30)$10.49 million$19.10 millionViewN/AView Earnings Details
7/31/2012($10.35)($9.90)ViewN/AView Earnings Details
5/8/2012($11.40)($28.20)ViewN/AView Earnings Details
2/27/2012Q4 2011($12.74)($19.51)ViewN/AView Earnings Details
11/1/2011($10.65)($14.55)ViewN/AView Earnings Details
8/2/2011($9.45)($14.25)ViewN/AView Earnings Details
5/5/2011($7.50)($11.40)ViewN/AView Earnings Details
2/28/2011($7.35)($7.65)ViewN/AView Earnings Details
11/4/2010Q3 2010($57.74)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Amyris (NASDAQ:AMRS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Amyris (NASDAQ AMRS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 11.30%
Institutional Ownership Percentage: 22.27%
Insider Trading History for Amyris (NASDAQ:AMRS)
Institutional Ownership by Quarter for Amyris (NASDAQ:AMRS)

Amyris (NASDAQ AMRS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/16/2018John MeloInsiderSell10,776$4.68$50,431.6883,172View SEC Filing  
5/19/2017Patrick Y YangDirectorBuy300,000$0.29$87,000.00153,000View SEC Filing  
4/20/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell652,513$0.55$358,882.15View SEC Filing  
4/18/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell1,636,930$0.65$1,064,004.50View SEC Filing  
3/30/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell184,535$0.51$94,112.85View SEC Filing  
3/29/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell417,990$0.51$213,174.90View SEC Filing  
3/27/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell129,059$0.48$61,948.32View SEC Filing  
3/23/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell165,428$0.48$79,405.44View SEC Filing  
3/21/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell223,073$0.48$107,075.04View SEC Filing  
3/20/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell88,382$0.49$43,307.18View SEC Filing  
3/17/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell339,908$0.49$166,554.92View SEC Filing  
3/15/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell270,374$0.46$124,372.04View SEC Filing  
3/13/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell346,429$0.50$173,214.50View SEC Filing  
3/9/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell520,925$0.46$239,625.50View SEC Filing  
3/7/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell852,224$0.45$383,500.80View SEC Filing  
3/3/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell868,589$0.49$425,608.61View SEC Filing  
3/1/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell377,823$0.51$192,689.73View SEC Filing  
2/27/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell287,706$0.52$149,607.12View SEC Filing  
2/23/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell529,747$0.53$280,765.91View SEC Filing  
2/21/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell287,528$0.56$161,015.68View SEC Filing  
2/16/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell390,918$0.54$211,095.72View SEC Filing  
2/10/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell429,198$0.51$218,890.98View SEC Filing  
2/8/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell288,765$0.50$144,382.50View SEC Filing  
1/12/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell29,502$0.81$23,896.62View SEC Filing  
1/11/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell451,806$0.81$365,962.86View SEC Filing  
1/9/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell1,072,847$0.81$869,006.07View SEC Filing  
12/14/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell87,291$0.80$69,832.80View SEC Filing  
12/12/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell54,286$0.80$43,428.80View SEC Filing  
12/8/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell285,623$0.81$231,354.63View SEC Filing  
12/6/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell578,550$0.81$468,625.50View SEC Filing  
12/2/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell556,296$0.84$467,288.64View SEC Filing  
11/22/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell77,383$0.80$61,906.40View SEC Filing  
11/17/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell509,779$0.81$412,920.99View SEC Filing  
11/15/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell648,342$0.81$525,157.02View SEC Filing  
11/11/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell427,904$0.81$346,602.24View SEC Filing  
11/8/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell333,811$0.82$273,725.02View SEC Filing  
11/4/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell2,611,233$0.89$2,323,997.37View SEC Filing  
10/17/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell2,300,000$0.83$1,909,000.00View SEC Filing  
6/14/2016L John DoerrDirectorBuy200,577$1.04$208,600.0815,000View SEC Filing  
10/14/2015Energies Nouvelles Activ TotalDirectorSell80,052$2.36$188,922.7264,178,185View SEC Filing  
6/5/2015John MeloCEOSell61,276$2.00$122,552.00View SEC Filing  
5/12/2015John MeloCEOSell65,575$2.08$136,396.00View SEC Filing  
5/15/2014L John DoerrDirectorBuy172,186$3.02$520,001.729,000View SEC Filing  
5/24/2013John MeloCEOSell24,402$2.85$69,545.70View SEC Filing  
3/27/2013Thani Sheikh Abdullah Bin K AlDirectorBuy1,533,742$3.26$4,999,998.92View SEC Filing  
12/24/2012Thani Sheikh Abdullah Bin K AlDirectorBuy3,355,704$2.98$9,999,997.92View SEC Filing  
8/31/2012John MeloCEOSell668,730$3.70$2,474,301.00View SEC Filing  
8/31/2012L John DoerrDirectorBuy270,270$3.70$999,999.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Amyris (NASDAQ AMRS) News Headlines

Source:
DateHeadline
Amyris sees a future beyond fuelsAmyris sees a future beyond fuels
www.bizjournals.com - April 20 at 8:23 AM
 Analysts Expect Amyris Inc (AMRS) Will Post Quarterly Sales of $24.12 Million Analysts Expect Amyris Inc (AMRS) Will Post Quarterly Sales of $24.12 Million
www.americanbankingnews.com - April 19 at 2:50 AM
Amyris (AMRS) vs. Its Peers Financial ContrastAmyris (AMRS) vs. Its Peers Financial Contrast
www.americanbankingnews.com - April 18 at 9:14 PM
Reviewing Amyris (AMRS) and Its PeersReviewing Amyris (AMRS) and Its Peers
www.americanbankingnews.com - April 18 at 9:31 AM
Stock Review for Specialty Chemicals Investors -- Aemetis, Amyris, Axalta Coating Systems, and Delta TechnologyStock Review for Specialty Chemicals Investors -- Aemetis, Amyris, Axalta Coating Systems, and Delta Technology
www.prnewswire.com - April 18 at 8:16 AM
Who Really Owns Amyris Inc (NASDAQ:AMRS)?Who Really Owns Amyris Inc (NASDAQ:AMRS)?
finance.yahoo.com - April 17 at 5:55 PM
Amyris (AMRS) Lowered to "Buy" at BidaskClubAmyris (AMRS) Lowered to "Buy" at BidaskClub
www.americanbankingnews.com - April 17 at 10:29 AM
Amyris Inc (AMRS) Receives Average Rating of "Buy" from BrokeragesAmyris Inc (AMRS) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 17 at 3:13 AM
Amyris (AMRS) Upgraded to "Hold" at Zacks Investment ResearchAmyris (AMRS) Upgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 12 at 5:09 PM
Options Traders Expect Huge Moves in Amyris (AMRS) Stock April 10, 2018Options Traders Expect Huge Moves in Amyris (AMRS) Stock April 10, 2018
www.zacks.com - April 10 at 5:30 PM
Options Traders Expect Huge Moves in Amyris (AMRS) StockOptions Traders Expect Huge Moves in Amyris (AMRS) Stock
finance.yahoo.com - April 10 at 5:30 PM
Comparing Amyris (AMRS) & Its RivalsComparing Amyris (AMRS) & Its Rivals
www.americanbankingnews.com - April 10 at 5:19 PM
Contrasting Amyris (AMRS) and Its PeersContrasting Amyris (AMRS) and Its Peers
www.americanbankingnews.com - April 9 at 9:19 AM
Head to Head Analysis: Amyris (AMRS) and Its PeersHead to Head Analysis: Amyris (AMRS) and Its Peers
www.americanbankingnews.com - April 5 at 9:30 AM
Amyris (AMRS) Cut to "Hold" at ValuEngineAmyris (AMRS) Cut to "Hold" at ValuEngine
www.americanbankingnews.com - April 3 at 7:34 PM
Amyris to Present at H.C. Wainwright Global Life Sciences Investment Conference on April 9, 2018Amyris to Present at H.C. Wainwright Global Life Sciences Investment Conference on April 9, 2018
finance.yahoo.com - April 3 at 5:35 PM
Head-To-Head Review: Amyris (AMRS) vs. Its RivalsHead-To-Head Review: Amyris (AMRS) vs. Its Rivals
www.americanbankingnews.com - April 2 at 11:06 AM
Amyris (AMRS) Earns "Buy" Rating from HC WainwrightAmyris (AMRS) Earns "Buy" Rating from HC Wainwright
www.americanbankingnews.com - April 2 at 8:03 AM
Financial Contrast: Stepan (SCL) and Amyris (AMRS)Financial Contrast: Stepan (SCL) and Amyris (AMRS)
www.americanbankingnews.com - March 30 at 3:24 AM
Amyris (AMRS) Given a $10.00 Price Target by B. Riley AnalystsAmyris (AMRS) Given a $10.00 Price Target by B. Riley Analysts
www.americanbankingnews.com - March 24 at 12:16 PM
Free Post Earnings Research Report: Chemours’ Quarterly Sales Jumped 19%; Turned Profitable Y-o-YFree Post Earnings Research Report: Chemours’ Quarterly Sales Jumped 19%; Turned Profitable Y-o-Y
finance.yahoo.com - March 23 at 8:18 AM
Q1 2018 EPS Estimates for Amyris Inc Decreased by Analyst (AMRS)Q1 2018 EPS Estimates for Amyris Inc Decreased by Analyst (AMRS)
www.americanbankingnews.com - March 22 at 9:24 AM
B. Riley Comments on Amyris Incs Q3 2019 Earnings (AMRS)B. Riley Comments on Amyris Inc's Q3 2019 Earnings (AMRS)
www.americanbankingnews.com - March 21 at 1:45 PM
UPDATE: Amyris, Inc. (AMRS) PT Raised to $10 at B.Riley/FBR - StreetInsider.comUPDATE: Amyris, Inc. (AMRS) PT Raised to $10 at B.Riley/FBR - StreetInsider.com
www.streetinsider.com - March 20 at 8:27 AM
Investors Buy Large Volume of Amyris Put Options (AMRS)Investors Buy Large Volume of Amyris Put Options (AMRS)
www.americanbankingnews.com - March 20 at 6:40 AM
Amyris, Q4 and FYE Earnings Release, Operational Highlights, and Analysts TargetAmyris, Q4 and FYE Earnings Release, Operational Highlights, and Analysts Target
finance.yahoo.com - March 19 at 5:18 PM
Amyris (AMRS) Soars: Stock Adds 14.7% in SessionAmyris (AMRS) Soars: Stock Adds 14.7% in Session
finance.yahoo.com - March 19 at 5:18 PM
Mid-Afternoon Market Update: Crude Oil Up 2%; Amyris Shares ... - NasdaqMid-Afternoon Market Update: Crude Oil Up 2%; Amyris Shares ... - Nasdaq
www.nasdaq.com - March 17 at 8:25 AM
Amyris (AMRS) CEO John Melo on Q4 2017 Results - Earnings Call TranscriptAmyris' (AMRS) CEO John Melo on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - March 16 at 6:30 PM
Edited Transcript of AMRS earnings conference call or presentation 15-Mar-18 8:30pm GMTEdited Transcript of AMRS earnings conference call or presentation 15-Mar-18 8:30pm GMT
finance.yahoo.com - March 16 at 6:30 PM
Here's Why Amyris Stock Jumped as Much as 28.5% Higher TodayHere's Why Amyris Stock Jumped as Much as 28.5% Higher Today
finance.yahoo.com - March 16 at 6:30 PM
10 Stocks To Watch For March 16, 2018 - Benzinga10 Stocks To Watch For March 16, 2018 - Benzinga
www.benzinga.com - March 16 at 8:19 AM
Amyris Reports Another Strong Quarter with Solid Operating ... - GlobeNewswire (press release)Amyris Reports Another Strong Quarter with Solid Operating ... - GlobeNewswire (press release)
globenewswire.com - March 16 at 8:19 AM
Amyris (AMRS) Posts  Earnings Results, Beats Expectations By $0.54 EPSAmyris (AMRS) Posts Earnings Results, Beats Expectations By $0.54 EPS
www.americanbankingnews.com - March 15 at 9:02 PM
When Will Amyris Inc (NASDAQ:AMRS) Become Profitable?When Will Amyris Inc (NASDAQ:AMRS) Become Profitable?
finance.yahoo.com - March 15 at 6:13 PM
Amyris Reports Another Strong Quarter with Solid Operating Performance and 2017 Revenue of $143.4 Million up 113% over 2016Amyris Reports Another Strong Quarter with Solid Operating Performance and 2017 Revenue of $143.4 Million up 113% over 2016
finance.yahoo.com - March 15 at 6:13 PM
Amyris (AMRS) Upgraded at Zacks Investment ResearchAmyris (AMRS) Upgraded at Zacks Investment Research
www.americanbankingnews.com - March 13 at 4:35 PM
Amyris (AMRS) Set to Announce Quarterly Earnings on ThursdayAmyris (AMRS) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - March 8 at 1:30 AM
Amyris (AMRS) Lowered to "Strong Sell" at ValuEngineAmyris (AMRS) Lowered to "Strong Sell" at ValuEngine
www.americanbankingnews.com - March 5 at 12:12 AM
With A -47.59% Earnings Drop, Is Amyris Inc’s (NASDAQ:AMRS) Performance A Concern?With A -47.59% Earnings Drop, Is Amyris Inc’s (NASDAQ:AMRS) Performance A Concern?
finance.yahoo.com - February 27 at 5:55 PM
Amyris Q4 Earnings Preview - Seeking AlphaAmyris Q4 Earnings Preview - Seeking Alpha
seekingalpha.com - February 27 at 8:18 AM
Amyris Inc (AMRS) Expected to Post Quarterly Sales of $67.64 MillionAmyris Inc (AMRS) Expected to Post Quarterly Sales of $67.64 Million
www.americanbankingnews.com - February 27 at 4:36 AM
Amyris to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15, 2018Amyris to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15, 2018
finance.yahoo.com - February 26 at 5:45 PM
Amyris (AMRS) Rating Increased to Sell at ValuEngineAmyris (AMRS) Rating Increased to Sell at ValuEngine
www.americanbankingnews.com - February 23 at 10:52 PM
Amyris (AMRS) to Release Earnings on WednesdayAmyris (AMRS) to Release Earnings on Wednesday
www.americanbankingnews.com - February 21 at 2:22 AM
Short Interest in Amyris Inc (AMRS) Rises By 34.7%Short Interest in Amyris Inc (AMRS) Rises By 34.7%
www.americanbankingnews.com - February 11 at 1:52 AM
Zacks: Analysts Expect Amyris Inc (AMRS) Will Announce Quarterly Sales of $67.64 MillionZacks: Analysts Expect Amyris Inc (AMRS) Will Announce Quarterly Sales of $67.64 Million
www.americanbankingnews.com - February 10 at 4:18 AM
Zacks: Analysts Expect Amyris Inc (AMRS) to Announce $0.04 Earnings Per ShareZacks: Analysts Expect Amyris Inc (AMRS) to Announce $0.04 Earnings Per Share
www.americanbankingnews.com - February 8 at 9:20 PM
Amyris Aprinnova Joint Venture Launches Pharmaceutical Grade Neossance Squalane USP – Opens New Market Among FDA Regulated ProductsAmyris Aprinnova Joint Venture Launches Pharmaceutical Grade Neossance Squalane USP – Opens New Market Among FDA Regulated Products
finance.yahoo.com - February 8 at 3:41 PM
Amyris Biossance Starts 2018 with Over 300% Retail Sales Growth – Now Available Across SEPHORA Canada StoresAmyris Biossance Starts 2018 with Over 300% Retail Sales Growth – Now Available Across SEPHORA Canada Stores
finance.yahoo.com - February 1 at 9:32 AM

SEC Filings

Amyris (NASDAQ:AMRS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Amyris (NASDAQ:AMRS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Amyris (NASDAQ AMRS) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.